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Abstract
Background: The adoption of ACT as the first line treatment for uncomplicated malaria in Nigeria has concentrated
attention on the role of testing in appropriate malaria treatment. There are calls at both national and global level
for malaria treatment to be based on test result, but it is still unclear how testing can be incorporated into
treatment-seeking and practices of health providers. This study explored community members and health providers’
perceptions and experiences with malaria tests in south east Nigeria.
Methods: The study was conducted in urban and rural areas of Enugu state in south-eastern Nigeria. A total of
18 focus group discussions with 179 community members including sub-groups of primary caregivers, adult men
and adult women aged 15 years and above. Twenty- six (26) In-depth interviews were held with public and private
health providers involved in prescribing medicines at public and private health facilities in the study area.
Results: Both providers and community members were familiar with malaria tests and identified malaria tests as
an important step to distinguish malaria from other illnesses with similar symptoms and as a means of delivering
appropriate treatment. However, the logic of test-directed treatment was undermined by cost of test and a lack of
testing facilities but above all concerns over the reliability of negative test results, with community members and
providers observing inconsistencies between results and symptoms, and providers attributing inaccurate results
to incompetencies of technicians. Recognition of malaria symptoms was deemed most important in determining
the use of antimalarial drugs rather than the result of a malaria test.
Conclusion: The results highlight important areas of intervention to promote appropriate malaria treatment. If tests
are to play a role in patient management, demand and supply side interventions are needed to change people’s
attitude towards malaria test results.
Background
The adoption of artemisinin combination therapy (ACT)
as first line treatment for malaria by many African coun-
tries including Nigeria has increased the emphasis on
accurate malaria diagnosis before treatment to prevent
the indiscriminate use of these drugs. In Nigeria, the
policy to treat malaria with ACT specifies that treatment
should be based on a parasitological test result where
testing is available [1]. There has been a global call for
parasitological confirmation by microscopy or with a
rapid diagnostic test (RDT) for patients of all ages with
suspected malaria [2]. The Roll Back Malaria partnership
also set new targets of universal access to malaria diag-
nostic testing in public and private sectors as well as at
the community level [3], but evidence suggests limited
role of tests in Nigeria for malaria case management
with only about 5% of children under-5 with fever being
tested [4]. The scaling-up of diagnostic testing is critical
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to ensure appropriate management of malaria and non-
malarial febrile illnesses and target anti-malarial medi-
cines to those who actually need them [3]. In Nigeria it
is not clear how these tests are perceived and how they
could be incorporated into current treatment-seeking
and prescribing practices of health care providers.
Studies have shown that reliable diagnostic testing is
severely limited in Africa, and misdiagnosis commonly
occurs, which exacerbates morbidity, promotes the per-
ception that testing is not useful, and compromises
patient care [5]. Where these tests are being provided,
there are common perceptions and beliefs about their
accuracy and impact on patient care. For instance in
Tanzania, a study found that although clinicians and
patients/caretakers were comfortable with overall per-
formance of laboratories, test results had limited impact
on patient management [6]. In Nigeria, a study on avail-
ability and use of RDTs in public and private health
facilities found limited use of RDTs in these facilities
the main reasons given for non-use were unreliability of
RDTs, supply issues, and preference for other methods
of diagnosis [7].
In a number of settings, the introduction of RDTs has
not been found to affect case management, with many
patients continuing to be treated for malaria with nega-
tive results [8,9]. Social research across different settings
has suggested that this over diagnosis is part of the
culture of care in areas with a long history of malaria
and that simply introducing new technologies to identify
parasites fits poorly with priorities of local providers
and patients [10,11]. Concerns over testing also arise
from studies that have described how the practice of tak-
ing blood may be interpreted differently to biomedical
intentions [12,13]. For instance, in Uganda, it was
reported how community members feared that blood
collected for malaria testing could be used for HIV test-
ing or witchcraft and that children could be infected
with HIV leading the authors to suggest that a well-
designed behaviour change communication strategy
is needed to address the anticipated programmatic
challenges [14].
The Government of Nigeria plans to introduce RDTs
in health facilities in Nigeria, but little is known from
the social perspective about what challenges may be
faced with implementation and scale up of these tests
in this setting. Since the acceptance of any healthcare
intervention depends on people’s perception of the
innovation amongst other factors [15], it becomes cru-
cial to explore people’s perception and experiences with
malaria tests. Prior to a randomized control trial where
RDTs will be introduced to health care providers and
community members educated on the importance of
appropriate diagnosis and treatment, the views of pro-
viders and community members who are potential
recipients of these interventions were explored. This
paper presents findings from this baseline study under-
taken in south-eastern Nigeria.
Methods
Study area
The study was carried out in Enugu state in 2010. The
state is geographically located in the south-eastern zone
of Nigeria. It has a land area of 7,700 square kilometres
and a population of over 3 million people [16]. Two sites
were chosen; Enugu which is the largest predominantly
urban area in Enugu State and Udi a rural area. The
study sites are similar in culture and have a mix of both
public and private facilities. Malaria is endemic in both
sites, and occurs all year round. Government provides
health care services through the primary health centres,
secondary and tertiary hospitals. There are in addition,
private laboratories and hospitals together with pharma-
cies and patent medicine dealers (PMDs) that are pri-
vately owned. At primary health facilities, treatment of
malaria is free for pregnant women and children under-
5 despite, although studies show that pharmacies and
PMDs have remained a major source for the treatment
of malaria [17]. Pharmacies and PMDs are licensed to
sell over the counter pharmaceutical products. These
facilities are medicine retailers and do not routinely offer
clinical care or diagnostic services. A few primary health
care facilities offer diagnostic tests [9].
Study design
Information was collected through qualitative methods
which consisted of focus group discussions (FGDs) with
community members and in-depth interviews (IDIs)
with health care providers in the two study areas. In
each of the site, three (3) communities were randomly
selected and in each community FGDs were held with
three sub-groups of community members chosen to rep-
resent those seeking care most frequently: primary care-
givers, adult men and adult women aged 15 years and
above. Women of 15 years and above were included
because at this age, they are considered old enough to
marry. A total of 18 focus group discussions were con-
ducted with 179 community members.
Health facilities were selected from a list obtained
from census of health facilities (both public and private)
in the study area. A total of 26 health facilities were
included in the study, 13 facilities in each site. In all,
twenty- six (26) in-depth interviews were conducted
with public and private health providers including
nurses, midwives, nursing assistants, community Health
Extension Workers, Community Health Officers, Phar-
macy Representatives and patent medicine dealers
involved in prescribing medicines.
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Selection of participants and data collection
FGDs were held with community members, prior to the
interviews, the research team identified members of the
communities as contact persons. Selection of partici-
pants was carried out by approaching contact persons
for the research in each of the study communities and
asking them to invite 8-12 participants according to the
inclusion criteria at a certain date and time to a conveni-
ent venue. Topics for the FGDs included knowledge
of and experience with malaria test, preferences and
trust in test results, views about importance of tests
and whether they will be happy to go for tests if
made available.
In-depth interviews (IDIs) were held with health care
providers from selected public and private facilities. This
method was chosen for providers because of their het-
erogeneity in cadre and geographical distances. The
facilities included were primary health centres, patent
medicine dealers and pharmacies. These types of facil-
ities were chosen because they serve as the commonest
source of malaria treatment in this region. In each of the
selected health facilities, one health provider was inter-
viewed who has a role in prescribing or dispensing.
Topics for the in-depth interviews included role of
malaria diagnosis and testing in their treatment and pre-
scribing practices, views and experience with diagnostic
tests, trusts and logistics of diagnostic tests and views on
community preferences for tests.
For both FGDs and IDIs, demographic information of
participants including age, occupation, marital status,
level of education was recorded using the enrolment
forms. At the start of the interviews, participants were
given information sheets and told the purpose of the
study. They were then asked to provide written consent.
Where written consent could not be provided, oral con-
sent was obtained. Participants were given codes to
ensure anonymity and interviews were coded according
to study site and participant category. The study team
comprised of seven facilitators and seven note-takers
trained over 5 days using a standard social science field
manual developed for the study. Interviews commenced
after the pre-test and revision of study tools. Two (2)
coordinators and a lead sociologist supervised the inter-
views. The facilitators moderated the interviews follow-
ing a topic guide. Responses were recorded with digital
voice recorders as well as through hand-written notes;
an observer was present at each interview to ensure that
all the questions were covered. All FGDs and IDIs were
conducted in the native Igbo language.
Data management
The audio files of FGDs and IDIs were transferred to the
computer immediately after each interview and were
transcribed and translated by trained note takers within
48 hours of conducting the interview. All interviews
were proof-read by the supervisors to ensure the accur-
acy and consistency of transcription. Each interview was
labelled according to site and category of participant(s).
Data analysis
Transcripts and information from enrolment forms were
imported into NVivo software version 8 (QSR Inter-
national). They were read carefully and coded according
to the responses of the respondents. The first three tran-
scripts were done by three different people and then
merged; this was done to ensure agreement of a coding
template between the coders. Emerging ideas were iden-
tified and grouped into themes in a continuous revision
process as more transcripts were reviewed. Two sociolo-
gists then completed the coding. Analysis involved draw-
ing together themes based on the questions asked.
Ethical aspects
Approval to carry out the study was obtained from the
Ethics Review Board of the University of Nigeria
(UNTH/CSA.329) and the London School of Hygiene &
Tropical Medicine (Approval 5429).
Findings
A total of 179 community members participated in the
FGD and in more than half of the FGD groups, the
number of participants ranged from 10-12 (Table 1).
The lowest mean age of participant groups was 26 and
the highest was 55. Participants were all married and in
about half of the groups, the highest level of education
was secondary. In only a few groups were most people
unemployed. Table 2 shows that 58% of IDI respondents
were private drug retailers. The highest level of educa-
tion for majority was junior secondary education. The
mean age of respondents was 38 years. Majority of the
respondents were not originally from the area and most
(54%) have worked for about 1-5 years in the facilities.
The highest number of years of professional training for
the majority ranged from 11-15 years.
Key themes that were important across the different
sub-groups of participants were identified which
includes the frequency with which testing is used, the
perceived importance of testing, reasons for not using
malaria tests, trust in test results and when tests are
undertaken how the test results are used. These issues
are discussed further below.
Frequency of testing
Participants in about half of the FGDs acknowledged
having had malaria test. While they would not always
subject themselves to tests at all times, they would
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usually take their children to be tested when they sus-
pect them of having malaria.
‘. . .. . . What I do is to buy drugs from chemist and my
malaria is cured. But whenever my children become
sick I immediately take them to the hospital, the first
thing they do is to test them. And they will receive
treatment’. (P3 FGD, Enugu, Adult Men)
On the other hand, the perspective of the health care
providers was that only a few people, would consent to
testing; majority would typically ask to be treated
straight away. Amongst the reasons given by health pro-
viders on why people do not demand tests was their per-
ceived self-recognition of malaria and its symptoms.
‘They feel they really know what is wrong with them.
At times some will come and tell you that they have
malaria so you should give them medicine for
malaria, so when you try to convince them that it is
necessary to undergo test so that the sickness will be
well identified and positively treated, being villagers
ignorantly they wouldn’t like to go for test’. (IDI, Udi,
Drug Retailer)
‘Well for the period I have stayed with them here, just
a few would like to go for test. And the few, I mean the
elite among them’. (IDI, Udi, Drug Retailer)
The providers also emphasized that the duration of
the symptoms felt by patients affect whether they will be
willing to go for tests or not since a prolonged fever is
usually perceived as more serious
‘If someone comes in here with fresh malaria that is,
the one that started yesterday night or this morning
and he comes in here and you start suggesting test He
will not be willing but if one has had malaria for
sometime let’s say last week, or last month and give
this kind of story. We will say why don’t you go to the
lab so that we will make sure it is not malaria? then
that is the time he/she will submit and go for test’.
(IDI, Enugu, Pharmacy)
Importance of testing: provider & community perspective
Across 11 FGDs, Participants emphasized, the import-
ance of tests both for adults and children, in identifying
the sickness that one has. In their explanations, treat-
ment based on self-recognition of symptoms and clinical
judgement may lead to missing out on treating the par-
ticular ailment one has as malaria symptoms overlap
with those of other illnesses.
‘A times you might be suspecting that what is wrong
with you is malaria but when the test results comes
out it will show that it is typhoid’. (P4 FGD Enugu,
Adult Women).
Table 1 Demographic details of FGD participants
FGD GROUP
(IDNO)
no of
participants
Age
[mean]
Status in the
family [mode]
Marital
status [mode]
Highest level of
education [mode]
occupation
[mode]
Number of
children [mean]
FUNAAM01 11 54.9 Head Married Primary Farmer 2
FUNAPC01 9 26.1 Wife Married Secondary Unemployed 2
FUNSAM01 10 49.6 Head Married Primary Farmer 4
FUNSAW01 8 49.6 Wife Married Primary Farmer 5
FUNSPC01 9 26.1 Wife Married Secondary Unemployed 2
FUNSAM01 9 49.6 Head Married Primary Farmer 4
FUUMAW01 11 45 Wife Married Uneducated Farmer 5
FUUMPC01 8 27 Wife Married Secondary Trader 1
FUNAAW01 12 31.1 Wife Married Secondary Trader 4
FEABAM01 11 47 Head Married Primary Artisan 4
FEABAW01 12 34.6 Wife Married Secondary Trader 4
FEABPC01 9 29.3 Wife Married Secondary Unemployed 3
FENHAM01 12 53.17 Head Married Primary Trader 5
FENHAW01 9 28.6 Wife Married Secondary Civil Servant 3
FENHPC01 10 32.6 Wife Married Secondary Trader 4
FEOGAM01 10 43.3 Head Married Primary Civil Servant 1
FEOGAW01 12 27.8 Wife Married Secondary Artisan 3
FEOGPC01 7 32.1 Wife Married Secondary Civil Servant 3
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‘. . .some people may not go for test and take the
wrong drugs but if you go for test, they know that it
is malaria and treat it directly’. (P7 FGD, Enugu,
Adult Men)
‘I am advising all mothers, if your child is sick and
you go to the hospital, tell the medical doctor to refer
you people for test because it is test that will show
the main thing that is wrong with your child. A times
we mothers when our child is ill we start giving the
child malaria drugs but when we then go for test, it
will show us that what is wrong with our child is
not malaria but typhoid’. (P6 FGD, Enugu, primary
care giver)
In the same manner, health providers’ (In 15 of the
26 IDIs) in both public and private facilities while outlin-
ing the ill effects of clinical diagnosis to patients
described tests as desirable and very important in distin-
guishing malaria from other illnesses and to give appro-
priate treatment.
‘It is very important that anybody coming to complain
to non-medical or even a medical person,. . .it is
advisable to go for test so that . . .. it won’t be a matter
of guess work, because by so doing you may complicate
the persons sickness, but if you advise or tell the
person to do test in a very good lab, that will help to
at least narrow down the chances of making mistakes
giving somebody what the person might not require’.
(IDI, Enugu, Drug Retailer)
‘It is very important. If we were doing it, we would
have known if a patient has malaria actually or not
instead of doing guess work. A patient might be
suffering from typhoid and we will be treating
malaria’. (IDI, Udi, Health Centre, Community Health
Officer);
Importance of testing: categories of people providers
send for test
Although testing was widely acknowledged to be import-
ant, it appeared that not everyone who presents with
fever will usually be referred for a test. The health provi-
ders identified the different categories of patients they
would normally refer for test. These quotes reflect the
responses from the public providers:
‘Ok like a pregnant woman, I will quickly tell her to go
to the hospital and see a doctor or go for a lab check-
up’. (IDI, Enugu, Community Health Officer)
‘Yes there are like some patients that will come they
would name all the necessary malaria drugs and that
they had taken at home and yet they are still having
the symptoms you will now have to send them for test
to really confirm what is the problem before you now
administer your own treatment’. (IDI, Enugu, Health
Centre, Nurse)
‘There are some patients that will come with some
confusing signs and symptoms. They will present with
so many signs and symptoms at the same time
and you will not really be sure it is malaria then
you have to send them for test’. (IDI, Enugu, Health
Centre, Nurse).
The private providers however were of the opinion
that they will recommend tests to patients based on
Table 2 Demographic details of IDI participants
Variable N = 26 n(%)
Facility type
Public 11(42)
Private 15(58)
Cadre of health worker
Drug retailer/pharmacist 15(57)
Nurse 2(8)
Nursing assistant, CHEWS, Other cadres 9(35)
Age
30 and less 6(23)
31-41 8(31)
42-51 8(31)
52 and above 4(15)
Highest level of education
Primary 2(8)
Junior secondary 8(31)
Senior secondary 0(0)
School of Health 7(27)
Tertiary 7(27)
Refuse to answer 2(8)
Originally from region
Yes 8(31)
Years worked at facility
<1-5 14(54)
6-10 6(23)
11- 15 1(4)
16 and above 5(18)
Number of years of professional training
None 3(11)
<1 yr -5 yrs 10(38)
6 yrs-10 yrs 6(23)
11 yrs- 15 yrs 2(8)
16 yrs and above 5(18)
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their perceived seriousness of the illness and the
patient’s willingness to accept to be tested.
‘Village mentality cannot be over emphasized. There
are people you will refer to lab and from there they
will go to another place and buy what they want to
buy. So when you sit down with the person, dialogue
with the person, if the person is understandable, not a
group of person or particular types of person but
people that will understand me, then I give them that
referral’. (IDI Udi, Drug retailer)
‘Depending on the seriousness of the sickness, I might
ask some to go for test, while I use my initiative for the
others’. (IDI, Enugu, Drug Retailer)
Reasons for not testing: patients need money
When asked about reasons that people do not go for
test, providers were generally of the opinion that finan-
cial constraints deter people from having a malaria test,
in addition to cost issues an individual’s level of aware-
ness also play a role:
‘In my own understanding it is the issue of money.
Anything that concerns money here is a different
matter. If you tell the person, his response will be
which money would I use for test? The person prefers
to buy drugs given to him’. (IDI, Udi, Drug Retailer)
‘You see . . . very many of them do not have money
they are peasants they would prefer that you treat
malaria. But the few enlightened ones will say nurse I
want to go to test then you give them the lab form for
the test’. (IDI, Enugu, Nurse)
‘Yes they always say it is a waste of money for them to
go for test. They prefer to be treated then if the
sickness,. . . if they are not responding to the treatment
being given to them they will now agree to go for test’.
(IDI, Health Centre Nurse)
Reasons for not testing: lack of facilities for testing
Generally, for the health care providers in both public
and private facilities, there were reports that they still
treat based on signs and symptoms due to lack of equip-
ments for testing.
‘It is very important to test, because you can be
treating for malaria, and it turns out to be something
else, that is disturbing the person. But if you test you
are sure of what you are doing. But in our own case,
since we don’t have what we can use to test or a
laboratory, we just be treating them like that and
continue begging God’. (IDI, Udi, Community
Health Officer)
‘It is very important but we don’t have the facility for
testing’. (IDI, Enugu, Health Centre, Nurse)
They also expressed the importance of having such fa-
cilities to enable them to give appropriate treatment as
is currently being advocated by the National malaria
control programme.
‘Well, there are . . ..our impediments often time is not
having a lab, we need a rapid diagnostic
equipment. . .you know that kind of stuff, diagnosis is a
problem, most time you may end up with a blind
treatment when you don’t have a definitive result, you
may end up with eh.. you know a blind treatment that
will or may not even yield anything, a patient comes
to a doctor, you know, you must give a prescription to
send away the patient and then move back in
order. . ... in order for the lab to be ready, if you don’t
give them anything, they will not be happy’. (IDI,
Enugu, Pharmacy)
Reasons for not testing: community members views on
accuracy of lab tests
Despite the nominal acceptance of testing as an import-
ant step towards appropriate treatment, there were ob-
vious doubts in the outcomes of malaria tests; many
respondents shared their personal experiences of the
issue
‘In the case of tests, sometimes, it records error for
example; yesterday one of my brothers was having
fever and after going for the test, the laboratory result
recorded that there was nothing wrong with him.
Later, we went to another laboratory and it came back
positive with malaria parasite with typhoid and drugs
were prescribed immediately but we’ve not still seen
the result of the drug administered. But my concern
is that if two laboratory results came back
differently. . .what then is the need for testing?’
(P9, FGD, Adult Men)
‘There are some places you will go for lab test what
this particular lab is saying is not what the other
would say. The person ends up getting confused. . .. you
understand?’ (P7, FGD, Udi, Primary caregiver).
‘I have not seen any difference because whenever I take
my children to this lab they will be saying it is
malaria parasite; every time malaria parasite, every
time malaria parasite. When my neighbour will go
malaria parasite, I don’t know if it is the same thing
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or not. Every time malaria parasite; all the labs
malaria parasite; I don’t know’. (P4,FGD,Enugu,
Adult Women).
Reasons for not testing: health provider’s perspective on
accuracy of lab tests
The perceptions of providers of the accuracy of lab tests
corroborate the responses from community members.
Amongst providers, there was a general perception that
test results are not always accurate which they attributed
mainly to incompetencies of lab personnel.
‘The microscopic result. . .they are trying but
sometimes I think there are people that are not experts
in that field, may be they may just handle it but due
to carelessness they may mishandle some specimens
that have been collected from another patient and this
may have a contrary result’. (IDI Enugu, Health
Centre, Nurse).
‘Sometimes one lab result might be different from
another result of the same person, and same test is
run’. . . The accuracy is not constant at all’. (IDI, Udi,
Health Centre, Community Health Officer)
What people do with test results: community member’s
reaction if test is negative
Among participants, there were expressions of suspicion
and the need to go for another test for confirmation
when initial test is a negative. There were other interpre-
tations of negative test result:
‘When a test comes out negative and the person is still
sick, it may just be the handiwork of wicked people.
The person may have been poisoned, but the doctor, if
he is well grounded should refer the person to herbal
treatment because negative means its poison and it
will not appear on the test result’. (P4 FGD, Enugu,
Adult Women).
‘I would want to know why they have not discovered
what is wrong with me. I will go to another lab and
do the test again. Because I know that am not well’.
(P8 FGD, Udi, Adult Men).
Some mothers expressed that they would continue
treating with anti-malarials or get herbal medications for
their children.
‘If they say it is not malaria, I will get to my home
town and get traditional medicine to take’. (P6 FGD,
Enugu, Primary Caregivers).
‘I will not do anything. When I get home, I will
continue to give the child anti-malarials’. (P3 FGD,
Enugu, Primary Caregivers).
What people do with test results: Health providers’ views
on peoples’ reaction to negative malaria tests
Health providers’ responses echo some of the responses
provided by community participants. They reported that
community members are generally not happy about
negative test result, and often suspect the accuracy of
such, while some others may think the sickness is due to
supernatural forces.
‘Some of them will be unhappy because if it is malaria,
it is easier for them to treat but when the result is
negative and you tell them to go to the hospital, their
reaction is usually, what can this be? Some of them will
by themselves suggest that they want to go for typhoid
test. Surprisingly, a lot of patients do not want to go to
hospital’. (IDI, Enugu, Pharmacy)
‘Most of them are even discouraged they don’t accept’
. . .they will be complaining saying you should try
again . . .’ (IDI, Enugu, Health Centre, Nurse)
‘Some of the patients do take it seriously because in
our context they always feel that everything is
supernatural. If result is negative, it means that
somebody must have bewitched them’. (IDI, Enugu,
Health Centre, Nurse)
What people do with test result: testing is pointless if
plan to give an antimalarial anyway
When asked about what they do with tests results, some
health providers reported that malaria tests are not that
important since in most instances treatment is based on
what they see in a patient or what they are told.
‘It is not particularly important; we can do without
it that is when the symptoms are glaring’. (IDI, Enugu,
pharmacy).
Others mention that test results do not affect the type
of treatment they give.
‘. . .. . .even if I did conduct any test maybe because of
the signs and symptoms I have seen on the patients
and I want to administer anti malaria treatment on
the patient I will still use the same type of anti
malaria’. (IDI, Enugu, Health centre, Nurse)
Discussion
This study shows that both providers and community
members attach importance to the concept of testing
Ezeoke et al. Malaria Journal 2012, 11:368 Page 7 of 10
http://www.malariajournal.com/content/11/1/368
especially to distinguish malaria from other illnesses and
an important step towards appropriate treatment, how-
ever, what providers and community actually do with a
test result is different. For instance some of the provi-
ders were of the opinion that test result does not affect
the treatment they give. This finding is consistent with
what has been reported elsewhere where despite the
availability of diagnostics, patients with negative test
results continued to receive anti-malarials [6,8]. This
could be explained by the perception of providers that
tests results are not always accurate due to their seeming
lack of trust in the competence of laboratory personnel.
Perhaps a more worrying aspect on the part of commu-
nity members is the reported inconsistencies in test
results leading them to question the need for tests. Such
beliefs if not properly addressed could result in a lack of
demand for tests even if they are made available,
reinforce the current practice of presumptive treatment
for febrile illness and in turn, lead to the over use of
anti-malarials.
In this study, the reasons for not testing included the
unavailability of testing equipment in health facilities.
Despite the expressed desire to carry out tests, lack of
testing equipment compels them to still use symptom-
based approach for diagnosis; this could limit the ability
of health providers to look for other causes of fever in
non malaria febrile illnesses as all febrile cases are trea-
ted as malaria [8,18,19]. Thus it has been argued that
providers should be equipped with testing facilities to
enable treatment that is in line with a test result which
will also safeguard the efficacy of ACT [20]. As reported
in other setting [21], cost was mentioned as a barrier to
testing and this is not surprising since individuals bear
most of the cost of their treatment in this region and an
additional cost of test may increase the burden of pay-
ment on patients and could result in their refusal to go
for test. Though studies have identified that even when
traditional barriers to testing such as availability and
cost are minimized, people’s perceptions and practice
behaviours emerge as continued barriers to use of test
results [22].
An issue of concern emanating from this study is the
notion of recommending tests to certain categories of
people. In both the public and private facilities a com-
mon category was pregnant women, those who have pre-
viously had antimalarials but not recovered and patients
with confusing symptoms. This could be because health
messages have often portrayed certain categories of
people like pregnant women as more vulnerable to mal-
aria. While it suffices to give appropriate treatment to
vulnerable groups, this impression could pose a problem
if it becomes normal practice because even when these
tests are made available, not everyone who presents with
fever may get a chance to be tested as is currently being
advocated. It will thus benefit National Malaria Control
Programmes if health messages and treatment algo-
rithms emphasize the importance of testing every febrile
patient. Addressing this issue will help to improve access
to proper treatment to everyone and to achieve the Roll
Back Malaria (RBM) target of universal access to malaria
diagnostic testing.
Both providers and community members expressed
reservation and a lack of trust for a negative malaria test
result and deem it necessary to repeat the same test for
malaria elsewhere rather than explore other causes of
the illness. This lack of trust in test result has been
reported in other studies for microscopy as well as for
RDTs [21,23,24] and have often resulted in continued
prescription of antimalarials [8,24,25]. Other interpreta-
tions of negative test results were also found in this
study, for instance there were views that in the event of
a negative result, the illness could then be due to the ac-
tivities of witchcraft or poison, or could be due to super-
natural forces. This is similar to what was reported by
Muela et al [26] where 62% of respondents shared the
view that witches could interfere with normal malaria by
hiding the parasites and making them invisible and thus
undetectable. The authors attributed the interpretation
of malaria in terms of witchcraft as being possible when
biomedical treatment does not provide the expected out-
come hence people give their own interpretation of the
illness when the outcome does not conform to their pre-
conception [26]. This belief could lead to further delays
in seeking treatment and in treatment being sought from
unorthodox health care providers.
One practical limitation of this study was that it was
carried out at a time that RDTs had not been widely
used by the cadre of health providers involved in the
study, thus many people had not seen or experienced
them. Their perceptions may thus differ when they have
utilized these tests. Finally, this study was done in one
state in the country and may not be generalisable to the
whole country especially with existing diverse ethnic and
religious groups.
In conclusion, the study shows that perceived import-
ance of malaria tests by health providers and community
members does not translate to trust in the results and
thus test results may be of limited use in patient man-
agement. Consequently, introducing testing equipments
may overcome the barrier of unavailability, but not some
of the perceptions about accuracy and usefulness of
tests. If tests are to be incorporated into treatment-
seeking and provision, there should be behavioural
change interventions for both the providers and commu-
nity. In the first instance testing facilities should be
made available in health facilities and health providers
properly trained on how to perform tests. This should
be backed up by supportive visits and supervision to
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ensure that providers adhere to testing guidelines and
treat based on test results. Proper training has been
shown to improve health provider’s ability to accurately
perform tests, improve their confidence in the results
and foster their acceptability in the community [14,27].
The use of supportive supervision was also reported to
be effective elsewhere [19]. Health worker training on
malaria case management should also emphasize better
ways of communicating with patients on the need for
tests. Treatment algorithms that clearly indicate to test
everyone suspected of malaria should be provided, these
algorithms should also indicate the course of action for
a negative test result.
Though it is not evident on what mix of interventions
will work in this setting, getting evidence about the
effectiveness of alternative intervention strategies is
important. A cluster randomized trial following on from
this study is ongoing to assess the impact of a combin-
ation of approaches on treatment-seeking and provider
prescribing in public and private facilities (clinicaltrials.
gov NCT01350752).
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